Beyond IgE—When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?
Anaphylaxis in humans is inherently difficult to study due to the acuteness of symptoms and the lack of biomarkers serving as risk predictors. Most cases are related to IgE sensitizations to foods, insect venoms, and drugs with mastocytosis patients forming a smaller risk group. However, identifying...
Main Authors: | Lars K. Poulsen, Bettina M. Jensen, Vanesa Esteban, Lene Heise Garvey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.00871/full |
Similar Items
-
Mast Cells and Basophils in IgE-Independent Anaphylaxis
by: Krzysztof Pałgan
Published: (2023-08-01) -
Salicylaldehyde Suppresses IgE-Mediated Activation of Mast Cells and Ameliorates Anaphylaxis in Mice
by: Tsubasa Ashikari, et al.
Published: (2022-08-01) -
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
by: Monica Thapaliya, et al.
Published: (2022-10-01) -
Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions
by: Tomoaki Ando, et al.
Published: (2021-07-01) -
Evaluation of the Luciferase Assay-Based In Vitro Elicitation Test for Serum IgE
by: Ryosuke Nakamura, et al.
Published: (2012-01-01)